Bird Flu May Have Brought Stock Advancement for CureVac, +11%
Bird Flu May Have Brought Stock Advancement for CureVac, +11%
禽流感或許爲curevac帶來了股票增長，漲幅11%。
$CureVac (CVAC.US)$, a company testing trail vaccines for influenza, climbed 11% Thursday after in part the news of three cases of a new strain of bird flu in the U.S., called H5N1. Reuters also reported cases in Mexico.
$CureVac (CVAC.US)$檢測流感試驗疫苗的公司CureVac(CVAC.US)週四上漲11%，部分原因是美國發現了一種被稱爲H5N1的新禽流感菌株的三個案例。路透社還報道了墨西哥的病例。
The firm dosed a patient with a phase 2 study on seasonal influenza as recently as last week, according to a press release.
據新聞稿介紹，該公司最近在季節性流感的二期臨床試驗中給一名患者進行了注射。